Equity Analysis

China Resources Beer: Analysts Eye Strong Upside

China Resources Beer enjoys investor confidence despite softer headline results. The brewer's share price strength, steady dividends and an attractive valuation, sets the stage for broader bullish...

Couche-Tard Drives Global Convenience Mobility Boom

Urbanization and shared mobility are energizing the convenience-and-mobility surge: Couche-Tard, bolstered by its vast network, US revenue dominance, and data-driven retail-mobility conversions,...

Unicredit: Bankers also dream of AI

Earnings/sales releases The release of the group’s Q4 results allowed the management to disclose upbeat plans for the next five years, targeting a 25% RoTE driven by technological tailwinds. If the...

Jarir Marketing Company is Plotting to Write a Bestseller

Jarir Marketing Company has hit a historic revenue milestone in FY 25. While the rise of official Apple stores and e-commerce giants create a competitive squeeze, Jarir is fighting back with...

Indus Towers Boosts Telecom Infrastructure

Indus Towers Limited is showing that steady execution still wins attention, with investors warming to its long-term narrative. The company is scaling up through digital integration and shared...

Steyr Motors AG: Solid FY25 results, conservative FY26 guidance leaves room for significant upside

Earnings/Sales releases Steyr's preliminary FY25 results align with revised guidance, with delayed orders leading to lower capacity utilisation, impacting FY25 performance. The company has issued a...

AP Moller-Maersk: Volatile 2026 outlook

Earnings/Sales releases The group delivered FY2025 results in line with guidance, despite a challenging macroeconomic and geopolitical environment. Ocean and Terminals performed well, supported by...

Coloplast: Kerecis setback and soft ostomy overshadow group growth

Earnings/Sales releases Coloplast delivered a weak Q1, with both revenue and adjusted EBIT missing consensus. Organic growth of 6% was in line with expectations, but softer-than-expected trends in...

H Lundbeck: Weak 2026 outlook a turn-off for investors

Earnings/Sales releases Q4 ‘25 results exceeded consensus, as Lundbeck met its 2025 Guidance. Strong growth for depression treatment Rexulti and migraine medicine Vyepti more than compensated for a...

Aperam: FY25 decent. But the much awaited FY26 is here!

Earnings/Sales releases Aperam reported satisfactory results for FY25, although Q4 slightly underperformed expectations. More significantly, the anticipated impact of the CBAM and new protectionist EU...

Industrivärden: Industrivärden's impressive Q4 25 concludes an excellent year

Earnings/Sales releases Industrivärden ended 2025 on a strong note and even overtook the almighty Investor by largely outperforming its index. The discount to NAV remains meagre but still positive ,...

Vinci: FY 2025: Free cash flow euphoria

Earnings/Sales releasesInvestors can pop the champagne this morning. Vinci just delivered a FY25 print with a record €7bn free cash flow, a higher €5.00 dividend, and a still-firing Energy...

Sampo: Solid FY25, but fading momentum and limited upside from here

Earnings/Sales releases Sampo delivered a solid set of FY25 results, although momentum faded in Q4 in terms of both GWP growth and Profitability, particularly in the UK. FY26 targets imply limited...

Qiagen: 2025 ended positively, entering 2026 with confidence

Earnings/Sales releases Qiagen's Q4 results surpassed both market expectations and management's Guidance, with most segments reporting gains. The 2026 Guidance aligns with expectations, and the...

Banco De Sabadell: Loaded quarterly release

Earnings/Sales releases The release of the fourth quarter results has been poorly received. Not only were the results fully in line with expectations, but the fine-tuned 2026 guidance stands slightly...

Danske Bank: Q4: Reclaiming the Nordic Bank Quality Seal

Earnings/sales releases Danske Bank’s Q4 results significantly beat consensus, driven by resilient NII and robust fee income growth. A 13.3% RoE and 100% FY-25 total distribution confirm its...

Orsted: FY25: Strategy confirmed, no delays announced in the US

Earnings/Sales Releases Results were slightly below expectations but generally reassuring, with no new negative developments. The strategy remains on track, although visibility beyond 2028 is limited....

Kone: Orders surprise positively, but 2026 targets are built into the narrative

Earnings/Sales releases In Q4, Kone reported a beat on orders , helped by stronger than expected demand in the new equipment business in North America, alongside sustained solid growth in...

Victrex: patience required for the polymer specialist

Victrex, a specialist in high-performance polymers, has never been a company for thrill seekers. Its materials sit deep inside aircrafts engines, medical implants and industrial equipment. Its latest...